Loading…
Based on limited metadata available, this Warning Letter was issued to 1 Party At A Time, a drug manufacturer or distributor, on September 1, 2020. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the metadata provided. The letter falls under FDA drug regulation oversight, though the specific issuing office is not identified in the available information. To understand the specific compliance issues cited, the complete Warning Letter text would need to be reviewed.